Efficacy News and Research

RSS
Fourth-quarter and full year fiscal 2009 results announced by AVANIR Pharmaceuticals

Fourth-quarter and full year fiscal 2009 results announced by AVANIR Pharmaceuticals

Positive data from Æterna Zentaris' Phase 2 targeted cytotoxic peptide conjugate study

Positive data from Æterna Zentaris' Phase 2 targeted cytotoxic peptide conjugate study

Cardiovascular risks associated with taking Vioxx could have been identified earlier, say researchers

Cardiovascular risks associated with taking Vioxx could have been identified earlier, say researchers

StemCells commences patient recruitment for a Phase I clinical trial of HuCNS-SC in PMD

StemCells commences patient recruitment for a Phase I clinical trial of HuCNS-SC in PMD

DSS sets evidence-based guidelines and definitions to treat type 2 diabetes

DSS sets evidence-based guidelines and definitions to treat type 2 diabetes

New data indicates early association between anti-inflammatory medication and cardiovascular risk

New data indicates early association between anti-inflammatory medication and cardiovascular risk

BioAlliance Pharma's AMEP biotherapy reduces both tumour growth and tumour angiogenesis

BioAlliance Pharma's AMEP biotherapy reduces both tumour growth and tumour angiogenesis

Scientists determine how insulin resistant drugs alter core biochemical pathways through systems biology approach

Scientists determine how insulin resistant drugs alter core biochemical pathways through systems biology approach

Human-derived UCB stem cell transplant has positive therapeutic effects on specific lung and heart disorders

Human-derived UCB stem cell transplant has positive therapeutic effects on specific lung and heart disorders

AmKor and Hengdian Group sign license agreement to develop and market new drug candidate in China

AmKor and Hengdian Group sign license agreement to develop and market new drug candidate in China

BioTrends Research Group releases Wave 2 report on AMAG's Feraheme

BioTrends Research Group releases Wave 2 report on AMAG's Feraheme

Caldolor Injection effective in treating fever in hospitalized burn patients

Caldolor Injection effective in treating fever in hospitalized burn patients

GI Dynamics to present interim data on its EndoBarrier Gastrointestinal Liner study

GI Dynamics to present interim data on its EndoBarrier Gastrointestinal Liner study

FDA grants Fast Track designation for ARCA biopharma's Gencaro

FDA grants Fast Track designation for ARCA biopharma's Gencaro

Positive interim results from Nereus Pharmaceuticals' plinabulin VDA study for advanced NSCLC

Positive interim results from Nereus Pharmaceuticals' plinabulin VDA study for advanced NSCLC

Phase IIb/III clinical trial results of CINQUIL for pediatric EoE announced

Phase IIb/III clinical trial results of CINQUIL for pediatric EoE announced

New FluCide better than the older version

New FluCide better than the older version

100th patient enrolled in Atrium Medical's iCAST Atrium Registry Ultrasound Study

100th patient enrolled in Atrium Medical's iCAST Atrium Registry Ultrasound Study

Spectrum Pharmaceuticals, Handok Pharmaceuticals sign collaboration agreement

Spectrum Pharmaceuticals, Handok Pharmaceuticals sign collaboration agreement

Raptor Pharmaceutical announces results of NGX426 clinical trial

Raptor Pharmaceutical announces results of NGX426 clinical trial

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.